Data is not available at this time.
Universal Corporation operates as a global leaf tobacco supplier, serving manufacturers of tobacco products across multiple regions. The company sources, processes, and supplies flue-cured and burley tobacco, catering primarily to large cigarette producers. Its vertically integrated operations span procurement, processing, and logistics, ensuring consistent quality and supply chain efficiency. UVV holds a strong position in the agricultural commodity sector, leveraging long-term relationships with growers and customers to mitigate volatility. The company also explores diversification into plant-based ingredients and other agricultural products, though tobacco remains its core revenue driver. Regulatory pressures and declining smoking rates in developed markets pose challenges, but UVV maintains resilience through geographic diversification and cost leadership. Its market position is reinforced by scale, expertise, and a reputation for reliability in a highly specialized industry.
Universal Corporation reported revenue of $2.75 billion for FY 2024, with net income of $119.6 million, reflecting a net margin of approximately 4.4%. Diluted EPS stood at $4.78, indicating stable profitability despite operating cash flow challenges (-$74.6 million), partly due to working capital adjustments. Capital expenditures of $66.0 million suggest disciplined reinvestment, though cash flow metrics warrant monitoring for cyclical impacts.
The company’s earnings power is underpinned by its asset-light processing model and contractual pricing mechanisms, which help stabilize margins. However, elevated total debt of $1.06 billion against cash reserves of $55.6 million signals leveraged operations, necessitating scrutiny of interest coverage and refinancing risks. Shareholder returns are supported by a consistent dividend, with a payout ratio of approximately 68% of diluted EPS.
UVV’s balance sheet reflects a leveraged structure, with total debt exceeding $1 billion against modest cash holdings. The debt-to-equity ratio appears elevated, though typical for commodity traders with seasonal working capital needs. Liquidity management remains critical, particularly given negative operating cash flow in the reporting period. The company’s ability to service debt hinges on stable tobacco demand and efficient inventory turnover.
Growth is tempered by secular declines in traditional tobacco markets, though emerging regions and alternative products offer partial offsets. The $3.24 annual dividend per share underscores a commitment to shareholder returns, with a yield likely appealing to income-focused investors. Future capital allocation may balance debt reduction with selective investments in diversification initiatives.
Trading at a mid-single-digit P/E multiple, UVV’s valuation reflects its mature industry status and moderate growth prospects. Market expectations appear calibrated to steady cash flows rather than expansion, with dividend sustainability being a key investor focus. The stock’s performance may hinge on commodity price stability and successful execution of non-tobacco ventures.
UVV’s entrenched supply chain relationships and processing expertise provide competitive moats. While tobacco demand faces headwinds, the company’s geographic reach and cost efficiency position it to navigate industry consolidation. Strategic shifts toward sustainable agriculture or nicotine alternatives could unlock incremental value, though near-term performance will likely remain tied to traditional markets.
10-K filing (CIK: 0000102037), company financial disclosures
show cash flow forecast
Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |